Litcius/Paper detail

Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies

Guiqing Xu, Xiaoqing Gong, Yingying Zhu, Xiaojun Yao, Lizeng Peng, Ge Sun, Jianxue Yang, Longfei Mao

2022Frontiers in Pharmacology22 citationsDOIOpen Access PDF

Abstract

was a novel and interesting IDO1 inhibitor for further development.

Topics & Concepts

ADMEErlotinibDocking (animal)TriazoleChemistryPharmacologyComputational biologyEGFR inhibitorsDrugCombinatorial chemistryStereochemistryBiochemistryMedicineBiologyEpidermal growth factor receptorOrganic chemistryReceptorNursingClick Chemistry and ApplicationsAdenosine and Purinergic SignalingTryptophan and brain disorders
Novel 1,2,3-Triazole Erlotinib Derivatives as Potent IDO1 Inhibitors: Design, Drug-Target Interactions Prediction, Synthesis, Biological Evaluation, Molecular Docking and ADME Properties Studies | Litcius